Kinetics of transhydrogenase reaction catalyzed by the mitochondrial NADH-ubiquinone oxidoreductase (Complex I) imply more than one catalytic nucleotide-binding sites
- PMID: 10050761
- DOI: 10.1016/s0014-5793(99)00062-9
Kinetics of transhydrogenase reaction catalyzed by the mitochondrial NADH-ubiquinone oxidoreductase (Complex I) imply more than one catalytic nucleotide-binding sites
Abstract
The steady-state kinetics of the transhydrogenase reaction (the reduction of acetylpyridine adenine dinucleotide (APAD+) by NADH, DD transhydrogenase) catalyzed by bovine heart submitochondrial particles (SMP), purified Complex I, and by the soluble three-subunit NADH dehydrogenase (FP) were studied to assess a number of the Complex I-associated nucleotide-binding sites. Under the conditions where the proton-pumping transhydrogenase (EC 1.6.1.1) was not operating, the DD transhydrogenase activities of SMP and Complex I exhibited complex kinetic pattern: the double reciprocal plots of the velocities were not linear when the substrate concentrations were varied in a wide range. No binary complex (ping-pong) mechanism (as expected for a single substrate-binding site enzyme) was operating within any range of the variable substrates. ADP-ribose, a competitive inhibitor of NADH oxidase, was shown to compete more effectively with NADH (Ki = 40 microM) than with APAD+ (Ki = 150 microM) in the transhydrogenase reaction. FMN redox cycling-dependent, FP catalyzed DD transhydrogenase reaction was shown to proceed through a ternary complex mechanism. The results suggest that Complex I and the simplest catalytically competent fragment derived therefrom (FP) possess more than one nucleotide-binding sites operating in the transhydrogenase reaction.
Similar articles
-
Kinetics of the transhydrogenase reaction catalyzed by mitochondrial NADH:ubiquinone oxidoreductase (complex I).Biochemistry (Mosc). 2002 Jun;67(6):651-61. doi: 10.1023/a:1016194120930. Biochemistry (Mosc). 2002. PMID: 12126472
-
The reaction mechanism of the mitochondrial pyridine nucleotide transhydrogenase. A study utilizing arylazido-pyridine nucleotide analogues.J Biol Chem. 1984 May 10;259(9):5945-53. J Biol Chem. 1984. PMID: 6715379
-
Energy-linked nicotinamide nucleotide transhydrogenase. Kinetics and regulation of purified and reconstituted transhydrogenase from beef heart mitochondria.J Biol Chem. 1982 Dec 25;257(24):14760-6. J Biol Chem. 1982. PMID: 7174665
-
Generation of superoxide by the mitochondrial Complex I.Biochim Biophys Acta. 2006 May-Jun;1757(5-6):553-61. doi: 10.1016/j.bbabio.2006.03.013. Epub 2006 Apr 17. Biochim Biophys Acta. 2006. PMID: 16678117 Review.
-
Mammalian NADH:ubiquinone oxidoreductase (Complex I) and nicotinamide nucleotide transhydrogenase (Nnt) together regulate the mitochondrial production of H₂O₂--implications for their role in disease, especially cancer.J Bioenerg Biomembr. 2011 Oct;43(5):541-64. doi: 10.1007/s10863-011-9381-4. Epub 2011 Sep 1. J Bioenerg Biomembr. 2011. PMID: 21882037 Review.
Cited by
-
Different Functions of Phylogenetically Distinct Bacterial Complex I Isozymes.J Bacteriol. 2016 Mar 31;198(8):1268-80. doi: 10.1128/JB.01025-15. Print 2016 Apr. J Bacteriol. 2016. PMID: 26833419 Free PMC article.
-
Reduction of the off-pathway iron-sulphur cluster N1a of Escherichia coli respiratory complex I restrains NAD+ dissociation.Sci Rep. 2017 Aug 18;7(1):8754. doi: 10.1038/s41598-017-09345-4. Sci Rep. 2017. PMID: 28821859 Free PMC article.
-
Adenosine 3',5'-cyclic monophosphate (cAMP)-dependent phosphoregulation of mitochondrial complex I is inhibited by nucleoside reverse transcriptase inhibitors.Toxicol Appl Pharmacol. 2008 Jan 1;226(1):94-106. doi: 10.1016/j.taap.2007.08.015. Epub 2007 Aug 25. Toxicol Appl Pharmacol. 2008. PMID: 17904600 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources